“Low levels of HER2 expression: new ideas for differentiated strategies in the choice of treatment for triple-negative breast cancers”, Вопр. онкол., vol. 69, no. 1, pp. 38–44, Mar. 2023, doi: 10.37469/0507-3758-2023-69-1-38-44.